Cannabidiol Discovery and Synthesis A Target-Oriented Analysis in Drug Production Process.

On Aug 12, 2020

. 2020 Aug 11.

doi: 10.1002/chem.202002887. Online ahead of print.

Affiliations

Item in Clipboard

Rodrigo Octavio Mendonça Alves de Souza et al. Chemistry. 2020.

Abstract

The current state of evidence and recommendations for cannabidiol (CBD) and its health effects change the legal landscape and aim to destigmatize its phytotherapeutic research. Recently, some countries have included CBD as an antiepileptic product for compassionate use in children with refractory epilepsy. The growing demand of CBD leads to the need for high purity cannabinoids for the emerging market. The discovery and development of approaches toward cannabidiol synthesis have arisen from the successful extraction of Cannabis plants for cannabinoid fermentation in brewer’s yeast. To understand the different contributions to CBD synthesis and its key intermediates, design, and enhancement, we offer a detailed analysis of the history behind cannabinoid compounds and their optimization.

Keywords: CBD; Organic Synthesis; cannabinoid; natural products.

Similar articles

The Pharmacological Basis of Cannabis Therapy for Epilepsy.

Reddy DS, Golub VM. Reddy DS, et al. J Pharmacol Exp Ther. 2016 Apr;357(1):45-55. doi: 10.1124/jpet.115.230151. Epub 2016 Jan 19. J Pharmacol Exp Ther. 2016. PMID: 26787773 Review.
The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study.

Reithmeier D, Tang-Wai R, Seifert B, Lyon AW, Alcorn J, Acton B, Corley S, Prosser-Loose E, Mousseau DD, Lim HJ, Tellez-Zenteno J, Huh L, Leung E, Carmant L, Huntsman RJ. Reithmeier D, et al. BMC Pediatr. 2018 Jul 7;18(1):221. doi: 10.1186/s12887-018-1191-y. BMC Pediatr. 2018. PMID: 29981580 Free PMC article. Clinical Trial.
Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.

Fasinu PS, Phillips S, ElSohly MA, Walker LA. Fasinu PS, et al. Pharmacotherapy. 2016 Jul;36(7):781-96. doi: 10.1002/phar.1780. Pharmacotherapy. 2016. PMID: 27285147 Review.
The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.

Reddy DS. Reddy DS. Clin Pharmacol Ther. 2017 Feb;101(2):182-184. doi: 10.1002/cpt.441. Epub 2016 Sep 29. Clin Pharmacol Ther. 2017. PMID: 27506704 Review.
A randomised controlled trial of vaporised Δ⁹-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.

Solowij N, Broyd S, Greenwood LM, van Hell H, Martelozzo D, Rueb K, Todd J, Liu Z, Galettis P, Martin J, Murray R, Jones A, Michie PT, Croft R. Solowij N, et al. Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):17-35. doi: 10.1007/s00406-019-00978-2. Epub 2019 Jan 19. Eur Arch Psychiatry Clin Neurosci. 2019. PMID: 30661105 Clinical Trial.

L’article Cannabidiol Discovery and Synthesis A Target-Oriented Analysis in Drug Production Process. est apparu en premier sur Cannabis Belgique.